to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.